ArticleExploration of targeted anti-tumor therapy2023

Receptor tyrosine kinase-like orphan receptor 1 inhibitor strictinin exhibits anti-cancer properties against highly aggressive androgen-independent prostate cancer.

Vignesh Sivaganesh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.